BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28424165)

  • 21. Low-dose anisomycin sensitizes glucocorticoid-resistant T-acute lymphoblastic leukemia CEM-C1 cells to dexamethasone-induced apoptosis through activation of glucocorticoid receptor and p38-MAPK/JNK.
    Liu Y; Ge J; Li Q; Guo X; Gu L; Ma ZG; Li XH; Zhu YP
    Leuk Lymphoma; 2014 Sep; 55(9):2179-88. PubMed ID: 24597985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin sensitizes glucocorticoid resistant acute lymphoblastic leukemia CEM-C1 cells to dexamethasone induced apoptosis through both mTOR suppression and up-regulation and activation of glucocorticoid receptor.
    Guo X; Zhou CY; Li Q; Gao J; Zhu YP; Gu L; Ma ZG
    Biomed Environ Sci; 2013 May; 26(5):371-81. PubMed ID: 23611130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ESRRB regulates glucocorticoid gene expression in mice and patients with acute lymphoblastic leukemia.
    Gallagher KM; Roderick JE; Tan SH; Tan TK; Murphy L; Yu J; Li R; O'Connor KW; Zhu J; Green MR; Sanda T; Kelliher MA
    Blood Adv; 2020 Jul; 4(13):3154-3168. PubMed ID: 32658986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic gatekeeper function of B-lymphoid transcription factors.
    Chan LN; Chen Z; Braas D; Lee JW; Xiao G; Geng H; Cosgun KN; Hurtz C; Shojaee S; Cazzaniga V; Schjerven H; Ernst T; Hochhaus A; Kornblau SM; Konopleva M; Pufall MA; Cazzaniga G; Liu GJ; Milne TA; Koeffler HP; Ross TS; Sánchez-García I; Borkhardt A; Yamamoto KR; Dickins RA; Graeber TG; Müschen M
    Nature; 2017 Feb; 542(7642):479-483. PubMed ID: 28192788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid resistance in two key models of acute lymphoblastic leukemia occurs at the level of the glucocorticoid receptor.
    Schmidt S; Irving JA; Minto L; Matheson E; Nicholson L; Ploner A; Parson W; Kofler A; Amort M; Erdel M; Hall A; Kofler R
    FASEB J; 2006 Dec; 20(14):2600-2. PubMed ID: 17077285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of potential glucocorticoid receptor therapeutic targets in multiple myeloma.
    Thomas AL; Coarfa C; Qian J; Wilkerson JJ; Rajapakshe K; Krett NL; Gunaratne PH; Rosen ST
    Nucl Recept Signal; 2015; 13():e006. PubMed ID: 26715915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantitative proteomic analysis reveals maturation as a mechanism underlying glucocorticoid resistance in B lineage ALL and re-sensitization by JNK inhibition.
    Nicholson L; Evans CA; Matheson E; Minto L; Keilty C; Sanichar M; Case M; Schwab C; Williamson D; Rainer J; Harrison CJ; Kofler R; Hall AG; Redfern CP; Whetton AD; Irving JA
    Br J Haematol; 2015 Nov; 171(4):595-605. PubMed ID: 26310606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization to Drug Treatment in Precursor B-Cell Acute Lymphoblastic Leukemia Is Not Achieved by Stromal NF-κB Inhibition of Cell Adhesion but by Stromal PKC-Dependent Inhibition of ABC Transporters Activity.
    Ruiz-Aparicio PF; Uribe GI; Linares-Ballesteros A; Vernot JP
    Molecules; 2021 Sep; 26(17):. PubMed ID: 34500796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition.
    Meyer LK; Delgado-Martin C; Maude SL; Shannon KM; Teachey DT; Hermiston ML
    PLoS One; 2019; 14(7):e0220026. PubMed ID: 31318944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.
    Miller AL; Webb MS; Copik AJ; Wang Y; Johnson BH; Kumar R; Thompson EB
    Mol Endocrinol; 2005 Jun; 19(6):1569-83. PubMed ID: 15817653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia.
    van Galen JC; Kuiper RP; van Emst L; Levers M; Tijchon E; Scheijen B; Waanders E; van Reijmersdal SV; Gilissen C; van Kessel AG; Hoogerbrugge PM; van Leeuwen FN
    Blood; 2010 Jun; 115(23):4810-9. PubMed ID: 20354172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin E2 stimulates cAMP signaling and resensitizes human leukemia cells to glucocorticoid-induced cell death.
    Roderick JE; Gallagher KM; Murphy LC; O'Connor KW; Tang K; Zhang B; Brehm MA; Greiner DL; Yu J; Zhu LJ; Green MR; Kelliher MA
    Blood; 2021 Jan; 137(4):500-512. PubMed ID: 33507291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis.
    Gu L; Gao J; Li Q; Zhu YP; Jia CS; Fu RY; Chen Y; Liao QK; Ma Z
    Leukemia; 2008 Nov; 22(11):2091-6. PubMed ID: 18685609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Erg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia.
    Chen DW; Saha V; Liu JZ; Schwartz JM; Krstic-Demonacos M
    Oncogene; 2013 Jun; 32(25):3039-48. PubMed ID: 22869147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of glucocorticoid sensitivity in 697 pre-B acute lymphoblastic leukemia cells after overexpression or silencing of MAP kinase phosphatase-1.
    Abrams MT; Robertson NM; Litwack G; Wickstrom E
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):347-54. PubMed ID: 15856297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia.
    Ploner C; Schmidt S; Presul E; Renner K; Schröcksnadel K; Rainer J; Riml S; Kofler R
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):153-60. PubMed ID: 15860257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Myb interacts with the glucocorticoid receptor and regulates its level in pre-B-acute lymphoblastic leukemia cells.
    Sarvaiya PJ; Schwartz JR; Geng CD; Vedeckis WV
    Mol Cell Endocrinol; 2012 Sep; 361(1-2):124-32. PubMed ID: 22516378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA.
    Abrams MT; Robertson NM; Yoon K; Wickstrom E
    J Biol Chem; 2004 Dec; 279(53):55809-17. PubMed ID: 15509554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to glucocorticoid-induced apoptosis in lymphoblastic leukemia.
    Kofler R; Schmidt S; Kofler A; Ausserlechner MJ
    J Endocrinol; 2003 Jul; 178(1):19-27. PubMed ID: 12844332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoplasmic micro heavy chain confers sensitivity to dexamethasone-induced apoptosis in early B-lineage acute lymphoblastic leukemia.
    Kim JM; Fang J; Rheingold S; Aplenc R; Wasserman R; Grupp SA
    Cancer Res; 2002 Aug; 62(15):4212-6. PubMed ID: 12154021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.